This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   Dec. 18, 2012

 



Drug used to treat HIV might defuse deadly staph infections
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a pathogen linked to hundreds of thousands of hospitalizations each year. The discovery arose from a serendipitous finding that was a part of a collaborative study between an assistant professor of microbiology, a bacteriologist, and an associate professor of microbiology and pathology and medicine, whose laboratories are adjacent to each other. More

We've got you covered
Dealing with infectious samples is risky enough.
Why increase your risk by overlooking transport regulations?

Saf-T-Pak provides the solutions required for 49 CFR compliance:


Drug-resistant Klebsiella pneumoniae rises across the US
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Klebsiella pneumoniae drug resistance has significantly increased since 1998 for all antimicrobial agents except for tetracycline, according to a study published online recently and in the January issue of Emerging Infectious Diseases. Researchers analyzed U.S. inpatient data from the Surveillance Network database, a national repository of antimicrobial susceptibility results from about 200 institutions, for the years 1998 through 2010. They found a total of more than 3.1 million Klebsiella pneumoniae susceptibility results. More

Global malaria battle stalls as financing gets tight
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Global funding for the fight against malaria has stalled in the past two years, threatening to reverse what the World Health Organization says are "remarkable recent gains" in the battle to control one of the world's leading infectious killers. After rapid expansion between 2004 and 2009, funding for malaria prevention and control leveled off between 2010 and 2012 — meaning there were fewer life-saving steps taken in hard-hit malarial regions such as sub-Saharan Africa. More



VA under scrutiny after Legionnaires' cases in Pittsburgh
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBrief Twenty-nine patients at the Veterans Administration hospital in Pittsburgh have been diagnosed with Legionnaires' disease since January 2011, raising questions about the institution's safety practices. Five of the cases "are known to have acquired the disease from the hospital," the VA said. Another eight were infected elsewhere, and the source of the infection in 16 cases cannot been determined. More

Capturing cancer cells with rough surfaces
Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Tumors often shed malignant cells that then travel through a person's bloodstream. Because these cells can seed metastases, cancer researchers want ways of detecting these circulating tumor cells to understand and prevent cancer progression. In a new study, researchers report a cheap method for capturing these cells using just a rough glass slide. More

German researchers create 'smart' test tube
Dark Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers in Germany may be on the way to solving the problem with their invention of "smart" test tubes. Researchers at the Fraunhofer Institute for Biomedical Engineering in Saarland developed a test tube that interacts with a central control network, according to a press release. Their primary goal is to enable specimen data to be processed automatically, particularly with regard to documentation. More


CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.


Frequent Internet use linked with positive outlook on cancer prevention, diagnosis
iHealthBeat    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Individuals who frequently use the Internet to find health information have a more positive outlook on cancer prevention and diagnosis than those who rarely seek such information online, according to a study published in the Journal of Communication, PhysBizTech reports. According to researchers, Internet use reduced cancer fatalism to a greater extent among individuals with less education and less health knowledge than among people with more education and more health knowledge. More

More physicians on track to get flu shots
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Physicians are close to achieving ambitious national objectives set for them for flu vaccinations, according to the Centers for Disease Control and Prevention. The Healthy People 2020 target is a 90 percent vaccination rate for health professionals. The findings come as the CDC is urging healthcare workers to prepare for what could be a more severe influenza season than usual. More

A breakthrough against leukemia using altered T-cells
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When Emma Whitehead was near death from leukemia, her parents sought an experimental treatment at the Children's Hospital of Philadelphia. It was one that had never before been tried in a child, or in anyone with the type of leukemia Emma, then 6, had. The experiment used a disabled form of HIV to reprogram Emma's immune system genetically to kill cancer cells. More



Hard-to-treat Myc-driven cancers may be susceptible to drug already used in clinic
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers driven by alterations in the Myc gene, according to data from a preclinical study. More

Georgia researchers find algal ancestor is key to how deadly pathogens proliferate
University of Georgia via Science Codex    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Long ago, when life on Earth was in its infancy, a group of small single-celled algae propelled themselves through the vast prehistoric ocean by beating whip-like tails called flagella. It's a relatively unremarkable tale, except that now, more than 800 million years later, these organisms have evolved into parasites that threaten human health and their algal past in the ocean may be the key to stopping them. More

Battle wound foam secures Pentagon funding
BBC    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers working on a foam designed to limit internal bleeding of soldiers injured on the battlefield have received $15.5 million from the U.S. military to continue their work. The foam is formed by two liquids, injected into the body, which mix, expand and harden to create an internal dressing. More
 



ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Dec. 11, 2012
Dec. 4, 2012
Nov. 27, 2012
Nov. 20, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063